Oyster Point Pharma to Participate in the Cowen 42nd Annual Health Care Conference Mar 1, 2022 04:05PM
Oyster Point Pharma to Participate in the Cowen 42nd Annual Health Care Conference Mar 1, 2022 04:05PM
Oyster’s (OYST) Tyrvaya is Meaningfully Differentiated, Can Reach $1B+ Peak Sales – Analyst Oct 18, 2021 09:32AM
Oyster Point's drug becomes first FDA-approved nasal spray to treat dry eyes Oct 18, 2021 07:10AM
Oyster Point Pharma to Participate in the 41st Annual Cowen Healthcare Conference Feb 25, 2021 04:01PM


Feb 25, 2021 04:01PM Oyster Point Pharma to Participate in the 41st Annual Cowen Healthcare Conference
May 19, 2020 06:08PM Oyster Point Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 15, 2020 05:48AM Oyster Point Pharma Inc. (OYST) Prices 3.75M Share Upsized Common Offering at $28/Sh
May 15, 2020 02:01AM Oyster Point Pharma Announces Pricing of an Upsized Offering of Common Stock
May 12, 2020 04:21PM Oyster Point Pharma Inc. (OYST) Commences 2.5M Share Public Offering of Common Stoc
May 12, 2020 04:20PM Oyster Point Pharma Proposed Public Offering of Common Stock
May 11, 2020 11:48AM Oyster Point Pharma (OYST) PT Raised to $65 at Cowen
Feb 24, 2020 08:00AM Oyster Point Pharma to Present at the Cowen 40th Annual Healthcare Conference
Feb 24, 2020 08:00AM Oyster Point Pharma to Present at the Cowen 40th Annual Healthcare Conference
Nov 25, 2019 05:32AM Cowen Starts Oyster Point Pharma (OYST) at Outperform, Street High $40 PT
Nov 5, 2019 09:10AM Oyster Point Pharma Announces Closing of Initial Public Offering